- cafead Jan 19, 2022 at 11:12: AM
via Pharmaceuticals company GSK’s chief scientific officer is jumping ship, dealing a blow to the drugmaker as it seeks to rebuild its pipeline of new medicines and gears up for a corporate split in the summer.
Hal Barron, the highly regarded US scientist and veteran of Roche and Genentech, was one of GSK chief executive Emma Walmsley’s key hires a few months after she took the helm in April 2017.
article source
Hal Barron, the highly regarded US scientist and veteran of Roche and Genentech, was one of GSK chief executive Emma Walmsley’s key hires a few months after she took the helm in April 2017.
article source